Interleukin-1: a cytokine that has potent antisecretory and anti-ulcer actions via the central nervous system
- PMID: 2260970
- DOI: 10.1016/s0006-291x(05)80075-0
Interleukin-1: a cytokine that has potent antisecretory and anti-ulcer actions via the central nervous system
Abstract
The present study was performed to determine if interleukin-1 (IL-1) acts as a chemical messenger in the central nervous system (CNS) regulation of gastric secretion and ulcer formation, using male Wistar rats. The central injection of IL-1 dose-dependently inhibited gastric acid secretion in pylorus-ligated rats at 100 times smaller doses than the peripheral injection of the cytokine. The action of IL-1 was long-lasting because its antisecretory effect was still evident at 8 hr after injection. Furthermore, it was observed that pretreatment with central IL-1 dose-dependently suppressed the development of gastric ulcers induced by water-immersion restraint stress, a well-established ulcerogenic procedure. These results clearly suggested for the first time that IL-1, a cytokine produced by activated monocytes/macrophages, acts centrally in the brain to exert gastric antisecretory and anti-ulcer actions.
Similar articles
-
Gastric antisecretory and antiulcer actions of interleukin-1. Evidence for the presence of an "immune-brain-gut" axis.J Clin Gastroenterol. 1992;14 Suppl 1:S149-55. J Clin Gastroenterol. 1992. PMID: 1629572
-
Central interleukin-1 beta-induced inhibition of acid secretion in rats: specificity of action.Life Sci. 1993;52(9):785-92. doi: 10.1016/0024-3205(93)90076-f. Life Sci. 1993. PMID: 8437508
-
[Effects of 3-hydroxymethyl-2-methylimidazo [2, 1-b] benzothiazole (NIK-228) on gastric acid secretion and various experimental peptic ulcers in rats].Nihon Yakurigaku Zasshi. 1991 May;97(5):287-96. doi: 10.1254/fpj.97.5_287. Nihon Yakurigaku Zasshi. 1991. PMID: 1879806 Japanese.
-
Potent inhibition of gastric acid secretion and ulcer formation by centrally and peripherally administered interleukin-1.Ann N Y Acad Sci. 1992;664:353-68. doi: 10.1111/j.1749-6632.1992.tb39774.x. Ann N Y Acad Sci. 1992. PMID: 1456663 Review.
-
Inhibition of gastric acid secretion and therapeutic results: is there any correlation?Ital J Gastroenterol. 1990;22 Suppl 1:2-4. Ital J Gastroenterol. 1990. PMID: 1983421 Review.
Cited by
-
Anti-ulcer effect of FK 506, immunosuppressive agent, in rats.J Gastroenterol. 1994 Jun;29(3):383-4. doi: 10.1007/BF02358382. J Gastroenterol. 1994. PMID: 7520322 No abstract available.
-
Intracisternal injection of orexin-A prevents ethanol-induced gastric mucosal damage in rats.J Gastroenterol. 2007 May;42(5):336-41. doi: 10.1007/s00535-007-2007-2. Epub 2007 May 25. J Gastroenterol. 2007. PMID: 17530356
-
Abstracts of selected papers presented at the 34th annual meeting of The Japanese Society of Gastroenterology. Utsunomiya, Japan, October 12-14, 1992.Gastroenterol Jpn. 1993 Dec;28(6):767-866. Gastroenterol Jpn. 1993. PMID: 8276169 No abstract available.
-
Effects of FK506, an immunosuppressive agent, on genesis of water-immersion stress-induced gastric lesions in rats.Dig Dis Sci. 1994 Apr;39(4):713-20. doi: 10.1007/BF02087412. Dig Dis Sci. 1994. PMID: 7512015
-
Evidence that gastric antisecretory action of lipopolysaccharide is not due to a toxic effect on gastric parietal cells.Dig Dis Sci. 1992 Jul;37(7):1039-44. doi: 10.1007/BF01300284. Dig Dis Sci. 1992. PMID: 1618051
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical